GlaxoSmithKline Pharmaceuticals Ltd
NSE:GLAXO

Watchlist Manager
GlaxoSmithKline Pharmaceuticals Ltd Logo
GlaxoSmithKline Pharmaceuticals Ltd
NSE:GLAXO
Watchlist
Price: 2 264.6001 INR -0.8%
Market Cap: 383.6B INR
Have any thoughts about
GlaxoSmithKline Pharmaceuticals Ltd?
Write Note

Intrinsic Value

The intrinsic value of one GLAXO stock under the Base Case scenario is 1 271.5883 INR. Compared to the current market price of 2 264.6001 INR, GlaxoSmithKline Pharmaceuticals Ltd is Overvalued by 44%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

GLAXO Intrinsic Value
1 271.5883 INR
Overvaluation 44%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
GlaxoSmithKline Pharmaceuticals Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
GLAXO
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for GLAXO cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about GLAXO?
Bearish
Neutral
Bullish

Fundamental Analysis

2 264.6001 INR
-0.8%
-0.8%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

GlaxoSmithKline Pharmaceuticals Ltd
IN
Pharmaceuticals
Market Cap
383.6B INR
IPO
Nov 3, 1994
Employees
3 840
India
Market Cap
383.6B INR
Industry
Pharmaceuticals
IPO
Nov 3, 1994
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about GlaxoSmithKline Pharmaceuticals Ltd

Provide an overview of the primary business activities
of GlaxoSmithKline Pharmaceuticals Ltd.

What unique competitive advantages
does GlaxoSmithKline Pharmaceuticals Ltd hold over its rivals?

What risks and challenges
does GlaxoSmithKline Pharmaceuticals Ltd face in the near future?

Has there been any significant insider trading activity
in GlaxoSmithKline Pharmaceuticals Ltd recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide P/S
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide P/E
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide P/OCF
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide P/FCFE
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide P/B
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide EV/S
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide EV/GP
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide EV/EBITDA
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide EV/EBIT
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide EV/OCF
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide EV/FCFF
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide EV/IC
for GlaxoSmithKline Pharmaceuticals Ltd.

Show me price targets
for GlaxoSmithKline Pharmaceuticals Ltd made by professional analysts.

What are the Revenue projections
for GlaxoSmithKline Pharmaceuticals Ltd?

How accurate were the past Revenue estimates
for GlaxoSmithKline Pharmaceuticals Ltd?

What are the Net Income projections
for GlaxoSmithKline Pharmaceuticals Ltd?

How accurate were the past Net Income estimates
for GlaxoSmithKline Pharmaceuticals Ltd?

What are the EPS projections
for GlaxoSmithKline Pharmaceuticals Ltd?

How accurate were the past EPS estimates
for GlaxoSmithKline Pharmaceuticals Ltd?

What are the EBIT projections
for GlaxoSmithKline Pharmaceuticals Ltd?

How accurate were the past EBIT estimates
for GlaxoSmithKline Pharmaceuticals Ltd?

Compare the revenue forecasts
for GlaxoSmithKline Pharmaceuticals Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of GlaxoSmithKline Pharmaceuticals Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of GlaxoSmithKline Pharmaceuticals Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of GlaxoSmithKline Pharmaceuticals Ltd compared to its peers.

Compare the P/E ratios
of GlaxoSmithKline Pharmaceuticals Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing GlaxoSmithKline Pharmaceuticals Ltd with its peers.

Analyze the financial leverage
of GlaxoSmithKline Pharmaceuticals Ltd compared to its main competitors.

Show all profitability ratios
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide ROE
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide ROA
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide ROIC
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide ROCE
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide Gross Margin
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide Operating Margin
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide Net Margin
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide FCF Margin
for GlaxoSmithKline Pharmaceuticals Ltd.

Show all solvency ratios
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide D/E Ratio
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide D/A Ratio
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide Interest Coverage Ratio
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide Altman Z-Score Ratio
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide Quick Ratio
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide Current Ratio
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide Cash Ratio
for GlaxoSmithKline Pharmaceuticals Ltd.

What is the historical Revenue growth
over the last 5 years for GlaxoSmithKline Pharmaceuticals Ltd?

What is the historical Net Income growth
over the last 5 years for GlaxoSmithKline Pharmaceuticals Ltd?

What is the current Free Cash Flow
of GlaxoSmithKline Pharmaceuticals Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for GlaxoSmithKline Pharmaceuticals Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
GlaxoSmithKline Pharmaceuticals Ltd

Current Assets 30.1B
Cash & Short-Term Investments 21.9B
Receivables 2.7B
Other Current Assets 5.6B
Non-Current Assets 7.3B
Long-Term Investments 118.5m
PP&E 3B
Intangibles 183.4m
Other Non-Current Assets 4B
Current Liabilities 18.1B
Accounts Payable 6.3B
Other Current Liabilities 11.8B
Non-Current Liabilities 2.6B
Long-Term Debt 41.8m
Other Non-Current Liabilities 2.6B
Efficiency

Earnings Waterfall
GlaxoSmithKline Pharmaceuticals Ltd

Revenue
35.6B INR
Cost of Revenue
-13.6B INR
Gross Profit
22B INR
Operating Expenses
-12.4B INR
Operating Income
9.6B INR
Other Expenses
-2.8B INR
Net Income
6.8B INR

Free Cash Flow Analysis
GlaxoSmithKline Pharmaceuticals Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

GLAXO Profitability Score
Profitability Due Diligence

GlaxoSmithKline Pharmaceuticals Ltd's profitability score is 82/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Exceptional 3-Year Average ROIC
Positive Gross Profit
Positive Free Cash Flow
82/100
Profitability
Score

GlaxoSmithKline Pharmaceuticals Ltd's profitability score is 82/100. The higher the profitability score, the more profitable the company is.

GLAXO Solvency Score
Solvency Due Diligence

GlaxoSmithKline Pharmaceuticals Ltd's solvency score is 77/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Negative Net Debt
Low D/E
Long-Term Solvency
77/100
Solvency
Score

GlaxoSmithKline Pharmaceuticals Ltd's solvency score is 77/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

GLAXO Price Targets Summary
GlaxoSmithKline Pharmaceuticals Ltd

Wall Street analysts forecast GLAXO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GLAXO is 2 972.79 INR with a low forecast of 2 575.5 INR and a high forecast of 3 412.5 INR.

Lowest
Price Target
2 575.5 INR
14% Upside
Average
Price Target
2 972.79 INR
31% Upside
Highest
Price Target
3 412.5 INR
51% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for GLAXO?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for GLAXO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

GLAXO Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

See Also

Discover More
What is the Intrinsic Value of one GLAXO stock?

The intrinsic value of one GLAXO stock under the Base Case scenario is 1 271.5883 INR.

Is GLAXO stock undervalued or overvalued?

Compared to the current market price of 2 264.6001 INR, GlaxoSmithKline Pharmaceuticals Ltd is Overvalued by 44%.

Back to Top